Analyze Diet
American journal of veterinary research2002; 63(5); 660-668; doi: 10.2460/ajvr.2002.63.660

Antimicrobial-induced endotoxin and cytokine activity in an in vitro model of septicemia in foals.

Abstract: To determine which antimicrobials that are used to treat neonatal foals with septicemia attributable to Escherichia coli will minimize endotoxin release from bacteria and subsequent activity of inflammatory mediators while maintaining bactericidal efficacy. Methods: Blood samples from 10 healthy foals. Methods: Escherichia coli isolates A and B were isolated from 2 septicemic foals, and minimal inhibitory concentrations (MIC) were determined for 9 antimicrobials. Five of these antimicrobials were tested in vitro at 2 and 20 times their respective MIC. Whole blood or mononuclear cells grown in tissue-culture media were incubated with 105 colony-forming units of E. coli and each antimicrobial or saline (0.9% NaCl) solution. After 6 hours, number of viable bacteria remaining was determined, and supernatant was tested for endotoxin and tumor necrosis activity. Results: Testing in whole blood was compromised by bactericidal effects of the blood itself. In mononuclear cell suspensions, each antimicrobial significantly reduced the number of viable bacteria to low or undetectable amounts. Antimicrobials did not differ significantly in efficacy of bacterial killing. Amikacin used alone or in combination with ampicillin resulted in significantly less endotoxin activity than did ampicillin, imipenem, or ceftiofur alone. There was a correlation between TNF-alpha and endotoxin activity. Conclusions: Aminoglycosides appear less likely to induce endotoxemia and TNF-alpha synthesis during bactericidal treatment of E. coli septicemia, compared with beta-lactam antimicrobials. Use of ampicillin, imipenem, or ceftiofur in the treatment of septicemic neonatal foals should be accompanied by appropriate treatment for endotoxemia.
Publication Date: 2002-05-16 PubMed ID: 12013465DOI: 10.2460/ajvr.2002.63.660Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research article investigates which antimicrobials minimally induce endotoxin release and inflammatory mediators when treating neonatal foals with septicemia caused by Escherichia coli. It finds that Aminoglycosides, such as Amikacin, induce less endotoxemia and TNF-alpha synthesis during treatment compared to beta-lactam antimicrobials.

Study Design and Methodology

  • The study included blood samples from 10 healthy foals with Escherichia coli isolates A and B that were collected from two septicemic foals. They tested for the minimal inhibitory concentrations (MIC) of nine different types of antimicrobials.
  • Five of these antimicrobials were further tested in vitro (in a controlled environment outside a living organism) at two and twenty times their respective MIC levels.
  • The blood samples or mononuclear cells were grown in tissue-culture media along with 105 colony-forming units of E. coli and each antimicrobial or a saline solution.
  • After incubation for six hours, the viable bacteria remaining were counted, and the endotoxin, as well as tumor necrosis, activity in the supernatant was then tested.

Results

  • The testing of whole blood was complicated due to the bactericidal effects already present in the blood samples.
  • In the mononuclear cell suspensions used, all tested antimicrobials effectively reduced the number of viable bacteria to low or virtually undetectable amounts. There was no significant difference in the bactericidal efficacy of the tested antimicrobials.
  • Amikacin, whether used alone or combined with ampicillin, resulted in significantly less endotoxin activity than did ampicillin, imipenem, or ceftiofur when used independently.
  • A correlational relationship was observed between TNF-alpha (a cell signalling protein involved in systemic inflammation) and endotoxin activity.

Conclusions

  • The study concluded that Aminoglycosides, such as Amikacin, were less likely to induce endotoxemia (the presence of endotoxins in the blood which can cause a catastrophic immune response) and TNF-alpha synthesis during the bactericidal treatment of E. coli septicemia.
  • This suggests that beta-lactam antimicrobials such as ampicillin, imipenem, or ceftiofur could potentially induce more endotoxemia and should therefore be used in conjunction with appropriate treatments for endotoxemia when treating septicemic neonatal foals.

Cite This Article

APA
Bentley AP, Barton MH, Lee MD, Norton NA, Moore JN. (2002). Antimicrobial-induced endotoxin and cytokine activity in an in vitro model of septicemia in foals. Am J Vet Res, 63(5), 660-668. https://doi.org/10.2460/ajvr.2002.63.660

Publication

ISSN: 0002-9645
NlmUniqueID: 0375011
Country: United States
Language: English
Volume: 63
Issue: 5
Pages: 660-668

Researcher Affiliations

Bentley, Adrienne P
  • Department of Large Animal Medicine, College of Veterinary Medicine, University of Georgia, Athens 30602, USA.
Barton, Michelle H
    Lee, Margie D
      Norton, Natalie A
        Moore, James N

          MeSH Terms

          • Animals
          • Animals, Newborn
          • Anti-Bacterial Agents / adverse effects
          • Anti-Bacterial Agents / pharmacology
          • Anti-Bacterial Agents / therapeutic use
          • Bacteremia / drug therapy
          • Bacteremia / immunology
          • Bacteremia / microbiology
          • Bacteremia / veterinary
          • Endotoxins / blood
          • Escherichia coli / metabolism
          • Escherichia coli Infections / drug therapy
          • Escherichia coli Infections / immunology
          • Escherichia coli Infections / microbiology
          • Escherichia coli Infections / veterinary
          • Horse Diseases / drug therapy
          • Horse Diseases / immunology
          • Horse Diseases / microbiology
          • Horses
          • In Vitro Techniques
          • Leukocytes, Mononuclear / drug effects
          • Leukocytes, Mononuclear / microbiology
          • Microbial Sensitivity Tests / veterinary
          • Tumor Necrosis Factor-alpha / biosynthesis
          • Tumor Necrosis Factor-alpha / immunology
          • Tumor Necrosis Factor-alpha / metabolism

          Citations

          This article has been cited 1 times.
          1. Campion S, Inselman A, Hayes B, Casiraghi C, Joseph D, Facchinetti F, Salomone F, Schmitt G, Hui J, Davis-Bruno K, Van Malderen K, Morford L, De Schaepdrijver L, Wiesner L, Kourula S, Seo S, Laffan S, Urmaliya V, Chen C. The benefits, limitations and opportunities of preclinical models for neonatal drug development. Dis Model Mech 2022 Apr 1;15(4).
            doi: 10.1242/dmm.049065pubmed: 35466995google scholar: lookup